Clin2
NCT06684028Worth exploringRecruiting

PET imaging of a new tracer for cancer patients

CancerSolid Malignancies

Part of Cancer clinical trials.

This study uses a new imaging agent called [68Ga]-FAPI-JNU to take detailed pictures of tumors with a PET/CT scan. It aims to see how well this tracer works in people with various types of cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old
  • You have been diagnosed with a cancerous (malignant) tumor
  • Your overall health status allows you to be up and about at least half the day (ECOG score 0-3)
  • You are willing to sign a consent form and follow the study procedures
  • You have no known allergies to the study tracer or alcohol
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06455761Recruiting· Early Phase 1
PET scan with a new tracer for solid tumors

This trial uses a special PET scan (68Ga-DOTA-NI-FAPI04) to get clearer images of various solid tumors. It may help doctors see your cancer better and plan your treatment.

Fuzhou
NCT06688305Recruiting· Early Phase 1
First human test of new PET scan agent for solid tumors

This trial tests a new imaging agent called 68Ga-NI-FAPI to see how well it works in a PET scan for people with different types of solid tumors. The goal is to help doctors better see and understand tumors.

Fuzhou, Fujian
NCT06740240Recruiting· Early Phase 1
68Ga-FAPI-Biotin PET/CT scan for cancer imaging

This trial tests a new PET/CT scan that uses a special tracer (68Ga-FAPI-Biotin) to help detect and see various solid tumors. It may provide more detailed images to guide treatment decisions.

Fuzhou
NCT05172310Recruiting· Phase 1
PET scan study using a new tracer for solid tumors

This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.

Stockholm
NCT07639801Not yet recruiting
New imaging scan to help diagnose solid tumors

This study tests a new type of imaging scan called 68Ga-FAPI-PSMA PET that may help doctors better detect and diagnose solid tumors like prostate, liver, ovarian, or endometrial cancer. You would receive the scan before having a biopsy or surgery.

NCT06916338Recruiting
PET imaging study using 18F-FAPI-04 for breast cancer

This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.

Qingdao, Shandong

Hear when a new Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.